AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares
Video analysis: CUPR
All videosNo video analysis for this stock yet. Request one from our team.
News: CUPR
Super Copper Featured at OTC Markets' Virtual Investor Conference, Presentation Replay Now Available
VANCOUVER, BC / ACCESS Newswire / August 31, 2026 / SUPER COPPER CORP. (CSE:CUPR)(OTCQB:CUPPF)(FSE:N60) ("Super Copper" or the "Company"), is pleased to announce that Zachary Dolesky, Founder and Chief Executive Officer, presented live at the Clean Energy & Metals Virtual Investor Conference on August 27, 2026, the proprietary investor conference series of OTC Markets Group.
Cuprina Holdings Falls 22% After 112% Rally — Here's Why CUPR Stock Is Trending
Cuprina stock surged 112% after FDA clearance for MEDIFLY Maggots before falling sharply in after-hours trading.
Cuprina Receives U.S. FDA 510(k) Clearance for MEDIFLY Maggots — the First U.S. Clearance for a Lucilia cuprina Maggot Debridement Product
SINGAPORE, June 15, 2026 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (“CUPR” or “the Company”), a biomedical company developing and marketing products for the chronic wounds, infertility, medical waste recycling, and cosmeceuticals sectors, today announced that an indirectly wholly-owned subsidiary of the Company, Cuprina Pte. Ltd. has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for MEDIFLY Maggots™, its medical-grade Lucilia cuprina larvae used in maggot debridement therapy (MDT).
